Recursion Pharmaceuticals Inc RXRX
$3.00
▼ -1.32%
($-0.04)
🔥 High Short Interest
📅 Earnings This Week
Open
$3.09
Prev Close
$3.04
Day Range
$2.95 – $3.11
52W Range
$2.77 – $7.18
Market Cap
$1.59B
Beta
1.08
EPS (TTM)
$-1.20
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-04-16 |
| Shares Out. | 529,910,000 |
| Website | recursion.com/ ↗ |
| Phone | 13026744089 |
| Employees | 600 |
| Revenue | $6.5M |
| Gross Profit | -$6.0M |
| Net Income | -$117.5M |
| Free Cash Flow | -$325.8M |
| Total Assets | $1.34B |
| Total Liabilities | $314.8M |
| Equity | $1.02B |
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Recursion Pharmaceuticals Inc is a publicly traded company under the ticker symbol RXRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-07-01)